Published 64 days ago
Premaitha (NIPT) has updated on trading in the year to March 31 2017. Of course, what matters is not historic trading but the future, that is to say the patent challenge by US corporate fascist bully-boys Ilumina. However, some numbers do matter...
Published 69 days ago
The issue with Genoma was flagged up in the interims pre-Christmas. It owes Premaitha (NIPT) £750,000. That debt looks like a bad debt because the Swiss company has - despite its parent company concluding a fundraise - been having financial issues. So Premaitha has gone to court and had Genoma made bankrupt.
Published 143 days ago
We have a new share tip out at 2PM today but here is one which has not dazzled yet. We tipped it an an 18p offer, the shares are now 11.75p-12.5p but we hope readers took our advice and averaged down at as low as 7.5p But the stock is now on a roll and is still cheap. You can catch our new hot tip for just £5 HERE but pro tem back to Premaitha (NIPT).
Published 238 days ago
Premaitha (NIPT) has announced that its Thai distributor. Geneplus, has formally signed an agreement to offer the Company's IONA test in the Center for Medical Genomics (CMG), Ramathibodi Hospital, Mahidol University, partnering with the Thailand Center of Excellence for Life Sciences.
Published 260 days ago
The Government has announced that as of 2018 it will offer free Non Invasive Prenatal Tests (NIPT) for Downs to women deemed to be at high risk - that is those over 38 years old. Right now it costs you £180 to have an NIPT test rather than an invasive one which has a 1% chance of killing your baby.
Published 263 days ago
And now to what has not, to date, been a good share tip. But it will be and at 9p-9.25p you should average down in Premaitha (NIPT) and buy. The AGM statement this week from chairman Adam Reynolds was upbeat.
Published 497 days ago
Tom Winnifrith was an insider which restricted him from explaining why shares in Premaitha (NIPT) have been weak of late. Now you can see. The company's largest shareholder Rupert Lywood is a total 100% prat
Published 548 days ago
Premaitha Health (NIPT) has welcomed the UK National Screening Committee recommendation to routinely offer non-invasive prenatal testing on the NHS to high-risk pregnant women, noting “this is the first time that non-invasive prenatal testing will be routinely available to high risk pregnant women on the NHS and sets a precedent that we expect other countries to follow in the near future” and that“Premaitha is uniquely positioned to bring the benefits of non-invasive prenatal testing to the NHS”
Published 558 days ago
Premaitha Health (NIPT) has noted an announcement from Illumina, Inc. of patent infringement suits against Premaitha's customer in Poland and Ariosa Diagnostics, a subsidiary of Roche, and their customer, The Doctors Laboratory, in the UK, while reiterating that it “continues to make a robust defence against earlier claims by Illumina and the board is confident that the IONA test does not infringe the patents as claimed in the earlier cases or in relation to today's announcement”
Published 564 days ago
Ok this was one of my less successful share tips of the year for 2015 but this time it really will come good. That will be the prompt for guffaws of laughter from Wildes, who is currently sitting on a sinking lifeboat from the doomed SS LGO Energy. But he who laughs last...
Published 595 days ago
Premaitha Health (NIPT) has announced Adgenix as its exclusive distributor in France and that Adgenix has already signed up its first laboratory customer - with a “contract for a minimum of three years to supply LaboSud with the IONA test”
Published 615 days ago
Premaitha (NIPT) has announced some pretty stunning results from an independent test of its IONA test published in the Journal of Ultrasound, Obstetrics in Gynecology. Dam, why did we not get ahead of the news and subscribe to that must read publication? It sounds gripping stuff.
Published 648 days ago
Premaitha Health (NIPT) has announced an agreement with the leading distributor of scientific products in Greece (Antisel SA) to provide its IONA test to clinical laboratories in the region and that it has been informed that American company Illumina, Inc. has added a third patent to its suit against it. Buy, sell or hold?
Published 671 days ago
This was not going to be my tip in the recently published book "The Magnificent 7" which you can download for free HERE. I was set to tip Optibiotix (OPTI) at c40p. Unfortunately for you (but fortunately for me since we own shares in the company) the share price has raced ahead to a 48p offer. I still think that they could head much higher and Zak Mir reckons that Optibiotix shares will be 60p by October. I think, that is what a chartist terms a long term view.
Published 774 days ago
The Daily Mail & BBC this weekend ran stories about how the NHS was doing trials which would see all pregnant women getting a non invasive pre-natal test for down's syndrome. The Mail piece sums it up HERE
Published 777 days ago
We have tipped Premaitha (NIPT) before and our readers have banked big gains on it Now the time is right for re-entry and so this Adam Reynolds biotech play was our second May share tip of the month.
Published 850 days ago
Last week was a bit of a stomach churner for Premaitha (NIPT). The shares zoomed for about 30 minutes as it announced a stunning deal to commercialise its IONA test. They the tanked as a US giant launched a patent infringement case. Today they are zooming – up 37% at 24p – but I am not selling. In fact I am just kicking myself for not buying more at 16p a week ago!
Published 892 days ago
Published 893 days ago
A few weeks earlier than we had expected, Premaitha Health (NIPT) has announced that it has received CE-mark approval for its Iona test and will therefore launch it commercially at once. This is good news and the shares are now 23.5p – 24.5p.
Published 901 days ago
Premaitha (NIPT) has announced that it is almost there on getting the crucial CE-mark for its IONA test. It has passed two key milestones including ISO 13485:2003 certification which confirms that Premaitha's quality management system has been approved as applicable to the design, development and manufacture of in vitro diagnostic reagents and associated software for non-invasive assessment of genetic abnormalities.
Published 931 days ago
One of the reasons that capitalism works while the alternative is doomed to fail is that failing companies can reinvent themselves.
Published 943 days ago
Shares in Premaitha (NIPT) have slipped back to 17-17.5p as part of the pre Christmas non Santa rally. Results for the 7 months to 30 September were largely a Vialogy tidy up and were no great shakes. It is what will happen in 2015 that matters.